The FDA granted Priority Review to satralizumab for MOGAD, a rare CNS demyelinating disease, backed by phase 3 METEOROID trial data showing a 68% risk reduction.

A novel speech-based model successfully distinguishes between nonfluent, logopenic, and semantic variants of primary progressive aphasia.

The AAP Committee on Infectious Diseases provides an updated set of recommendations for RSV vaccination among infants and children.

Increased risk for ischemic stroke is associated with a cancer diagnosis, and this risk may peak in the first 3 months following diagnosis.

Restricting sugar intake in utero and during the first years of life is linked to a reduced risk for dementia and Alzheimer disease in adulthood.

A new machine learning algorithm can use facial videos to detect diabetes and hypertension without more invasive sampling techniques.

Patients with newly diagnosed MS may see greater effects on acute inflammatory outcomes with BCDTs and high-efficacy therapies.

Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.

Socioeconomic deprivation in residential areas does not appear to influence blood-based markers of Alzheimer disease in older men over time.

Cancer mortality attributed to alcohol consumption is increasing throughout the US, particularly among men and those aged 55 years and older.

The AAN and AHS have issued updated 2026 practice guidelines for the pharmacologic prevention and treatment of migraine among ...

Flexible-dose tavapadon significantly improves motor symptoms among patients with early-stage Parkinson disease.